Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
298.14B | 287.56B | 293.36B | 291.27B | 285.52B | 293.00B | Gross Profit |
16.73B | 19.26B | 29.81B | 30.40B | 28.85B | 29.03B | EBIT |
8.61B | 10.45B | 21.38B | 22.09B | 21.14B | 20.54B | EBITDA |
25.34B | 28.65B | 46.37B | 42.78B | 39.83B | 36.96B | Net Income Common Stockholders |
10.04B | 7.83B | 20.79B | 16.76B | 15.32B | 12.92B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
27.90B | 29.92B | 44.89B | 39.87B | 37.03B | 26.20B | Total Assets |
510.27B | 503.39B | 477.01B | 478.15B | 471.92B | 448.33B | Total Debt |
112.63B | 98.88B | 101.48B | 117.19B | 92.70B | 92.06B | Net Debt |
84.73B | 68.96B | 56.59B | 77.33B | 55.67B | 65.86B | Total Liabilities |
218.37B | 206.98B | 206.63B | 221.84B | 198.55B | 192.19B | Stockholders Equity |
290.12B | 294.65B | 266.70B | 252.54B | 269.57B | 252.49B |
Cash Flow | Free Cash Flow | ||||
0.00 | -7.56B | 14.67B | 15.59B | 14.38B | -2.96B | Operating Cash Flow |
0.00 | 18.50B | 31.02B | 32.14B | 33.22B | 29.80B | Investing Cash Flow |
0.00 | -26.80B | -7.70B | -16.78B | -18.30B | -32.90B | Financing Cash Flow |
0.00 | -6.18B | -18.58B | -12.52B | -4.07B | 1.30B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
€834.16M | 15.33 | 2.96% | 2.12% | ― | ― | ||
66 Neutral | $4.50B | 12.28 | 5.32% | 248.52% | 4.13% | -12.36% | |
$2.27B | 20.92 | 4.60% | 4.26% | ― | ― | ||
$4.77B | 19.09 | 6.41% | 2.18% | ― | ― | ||
77 Outperform | ¥108.82B | 12.11 | 3.72% | 3.56% | 4.86% | ||
75 Outperform | ¥21.54B | 9.02 | 3.33% | 3.60% | 16.83% | ||
74 Outperform | ¥17.17B | 7.44 | 2.74% | 1.73% | -2.77% |